These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17459783)

  • 1. A randomized trial of PET scanning to improve diagnostic yield of direct laryngoscopy in patients with suspicion of recurrent laryngeal carcinoma after radiotherapy.
    de Bree R; van der Putten L; Hoekstra OS; Kuik DJ; Uyl-de Groot CA; van Tinteren H; Leemans CR; Boers M;
    Contemp Clin Trials; 2007 Nov; 28(6):705-12. PubMed ID: 17459783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
    de Bree R; van der Putten L; van Tinteren H; Wedman J; Oyen WJ; Janssen LM; van den Brekel MW; Comans EF; Pruim J; Takes RP; Hobbelink MG; Valdés Olmos R; van der Laan BF; Boers M; Hoekstra OS; Leemans CR
    Radiother Oncol; 2016 Feb; 118(2):251-6. PubMed ID: 26477395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
    Brouwer J; de Bree R; Comans EF; Akarriou M; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
    Radiother Oncol; 2008 May; 87(2):217-20. PubMed ID: 18329117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement.
    Brouwer J; Bodar EJ; De Bree R; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
    Eur Arch Otorhinolaryngol; 2004 Sep; 261(8):417-22. PubMed ID: 14625779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.
    van Hooren AC; Brouwer J; de Bree R; Hoekstra OS; Leemans CR; Uyl-de Groot CA
    Eur Arch Otorhinolaryngol; 2009 Sep; 266(9):1441-8. PubMed ID: 19043728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?
    Wedman J; Pruim J; van der Putten L; Hoekstra OS; de Bree R; van Dijk BAC; van der Laan BFAM
    Clin Otolaryngol; 2019 Mar; 44(2):124-130. PubMed ID: 30315624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging.
    de Bree R; van der Putten L; Brouwer J; Castelijns JA; Hoekstra OS; Leemans CR
    Oral Oncol; 2009; 45(4-5):386-93. PubMed ID: 19095487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer.
    Bongers V; Hobbelink MG; van Rijk PP; Hordijk GJ
    Cancer Biother Radiopharm; 2002 Jun; 17(3):303-6. PubMed ID: 12136522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy evaluation of laryngeal carcinomas by tyrosine-pet.
    De Boer JR; Pruim J; Burlage F; Krikke A; Tiebosch AT; Albers FW; Vaalburg W; Van Der Laan BF
    Head Neck; 2003 Aug; 25(8):634-44. PubMed ID: 12884346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.
    van der Putten L; Hoekstra OS; de Bree R; Kuik DJ; Comans EF; Langendijk JA; Leemans CR
    Mol Imaging Biol; 2008 Sep; 10(5):294-303. PubMed ID: 18622649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy.
    Brouwer J; Hooft L; Hoekstra OS; Riphagen II; Castelijns JA; de Bree R; Leemans CR
    Head Neck; 2008 Jul; 30(7):889-97. PubMed ID: 18213716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
    Yao M; Graham MM; Smith RB; Dornfeld KJ; Skwarchuk M; Hoffman HT; Funk GF; Graham SM; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1410-8. PubMed ID: 15590172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
    Périé S; Hugentobler A; Susini B; Balogova S; Grahek D; Kerrou K; Montravers F; Chater PE; St Guily JL; Talbot JN
    Otolaryngol Head Neck Surg; 2007 Oct; 137(4):647-53. PubMed ID: 17903585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Computerized tomography in the evaluation of the larynx after surgical treatment and irradiation].
    Misiti A; Macori F; Caimi M; Palmeggiani F; Falchetto Osti M; Iacari V; Anaveri G
    Radiol Med; 1997 Dec; 94(6):600-6. PubMed ID: 9524596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal and hypopharyngeal carcinomas after (chemo)radiotherapy: a diagnostic dilemma.
    Zbären P; Weidner S; Thoeny HC
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):147-53. PubMed ID: 18327034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of laryngeal cancer.
    Bryce DP
    J Otolaryngol; 1979 Apr; 8(2):105-26. PubMed ID: 430578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laryngeal radionecrosis versus recurrent cancer: a clinical approach.
    McGuirt WF; Greven KM; Keyes JW; Williams DW; Watson N
    Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):293-6. PubMed ID: 9557763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.
    Anzai Y; Carroll WR; Quint DJ; Bradford CR; Minoshima S; Wolf GT; Wahl RL
    Radiology; 1996 Jul; 200(1):135-41. PubMed ID: 8657901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.